Zymeworks Inc. Files 8-K Report
Ticker: ZYME · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1937653
Sentiment: neutral
Topics: 8-K, SEC filing, financials
TL;DR
Zymeworks filed an 8-K, likely with financial updates. Keep an eye out for details.
AI Summary
On September 2, 2025, Zymeworks Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD disclosure and other events. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Zymeworks Inc. is providing updated information to the SEC, which could include financial updates or disclosures of material events relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events.
Key Numbers
- 001-41535 — Commission File Number (Identifies Zymeworks Inc.'s filing with the SEC.)
- 88-3099146 — IRS Employer Identification No. (Tax identification number for Zymeworks Inc.)
Key Players & Entities
- Zymeworks Inc. (company) — Registrant
- Delaware (location) — State of incorporation
- 108 Patriot Drive, Suite A (location) — Principal executive offices address
- Middletown (location) — City of principal executive offices
- 19709 (location) — Zip code of principal executive offices
FAQ
What specific financial statements or exhibits are included in this 8-K filing?
The provided excerpt states that 'Financial Statements and Exhibits' are included as an item, but does not detail their content.
What 'Other Events' are being reported by Zymeworks Inc. in this filing?
The excerpt lists 'Other Events' as an item in the 8-K filing but does not specify what those events are.
What is the purpose of the 'Regulation FD Disclosure' mentioned in the filing?
The filing indicates a 'Regulation FD Disclosure' is included, which typically pertains to the public disclosure of material non-public information.
When was Zymeworks Inc. incorporated, and in which state?
Zymeworks Inc. was incorporated in Delaware, as indicated by the filing.
What is the principal executive office address for Zymeworks Inc.?
The principal executive offices of Zymeworks Inc. are located at 108 Patriot Drive, Suite A, Middletown, Delaware, 19709.
Filing Stats: 625 words · 3 min read · ~2 pages · Grade level 12.2 · Accepted 2025-09-02 06:58:56
Key Financial Figures
- $0.00001 — ich registered Common Stock, par value $0.00001 per share ZYME The Nasdaq Stock Mar
Filing Documents
- d88452d8k.htm (8-K) — 27KB
- d88452dex991.htm (EX-99.1) — 13KB
- g88452g0901235210989.jpg (GRAPHIC) — 4KB
- 0001193125-25-193351.txt ( ) — 162KB
- zyme-20250902.xsd (EX-101.SCH) — 3KB
- zyme-20250902_lab.xml (EX-101.LAB) — 18KB
- zyme-20250902_pre.xml (EX-101.PRE) — 11KB
- d88452d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated September 2, 2025 104 Cover Page Interactive Data File (embedded as Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ZYMEWORKS INC. (Registrant) Date: September 2, 2025 By: /s/ Leone Patterson Name: Leone Patterson Title: Executive Vice President, Chief Business Officer and Chief Financial Officer